title: Accumulation of phase-shift nanoemulsions to enhance MR-guided ultrasound-mediated tumor ablation in vivo.
abstract: Magnetic resonance-guided high intensity focused ultrasound (MRgHIFU) is being explored as a non-invasive technology to treat solid tumors. However, the clinical use of HIFU for tumor ablation applications is currently limited by the long treatment times required. Phase-shift nanoemulsions (PSNE), consisting of liquid perfluorocarbon droplets that can be vaporized into microbubbles, are being developed to accelerate HIFU-mediated heating. The purpose of this study was to examine accumulation of PSNE in intramuscular rabbit tumors in vivo. MR images were acquired before and after intravenous injection of gadolinium-containing PSNE. MR signal enhancement was observed in rabbit tumors up to six hours after injection, indicating that PSNE accumulated in the tumors. In addition, PSNE vaporization was detected in the tumor with B-mode ultrasound imaging, and MR thermometry measurements indicated that PSNE accelerated the rate of HIFU-mediated heating. These results suggest that PSNE could dramatically improve the efficiency and clinical feasibility of MRgHIFU.
authors.affiliation: Department of Mechanical Engineering, Boston University, Boston, MA, USA. jonathan.kopechek@gmail.com
authors.forename: Jonathan A
authors.initials: JA
authors.lastname: Kopechek
authors.forename: Eunjoo
authors.initials: E
authors.lastname: Park
authors.forename: Chang-Sheng
authors.initials: CS
authors.lastname: Mei
authors.forename: Nathan J
authors.initials: NJ
authors.lastname: McDannold
authors.forename: Tyrone M
authors.initials: TM
authors.lastname: Porter
mesh_terms: D000818:Animals; D045744:Cell Line, Tumor; D004655:Emulsions / Q000493:pharmacokinetics / Q000627:therapeutic use; D005466:Fluorocarbons / Q000493:pharmacokinetics* / Q000627:therapeutic use; D057086:High-Intensity Focused Ultrasound Ablation / Q000379:methods*; D008279:Magnetic Resonance Imaging / Q000379:methods*; D053769:Nanocapsules / Q000627:therapeutic use*; D009374:Neoplasms, Experimental / Q000378:metabolism* / Q000628:therapy; D011817:Rabbits; D025321:Surgery, Computer-Assisted / Q000379:methods*; D014018:Tissue Distribution; D016896:Treatment Outcome
chemical_list: D004655:Emulsions; D005466:Fluorocarbons; D053769:Nanocapsules